SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
4/A

Amendment to a previously filed 4

3,4,5
View HTML
4/A

Amendment to a previously filed 4

3,4,5
View HTML
4/A

Amendment to a previously filed 4

3,4,5
View HTML
4/A

Amendment to a previously filed 4

3,4,5
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe